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a b s t r a c t       
Ethnopharmacological relevance: Tropaeolum majus    L. (Tropaeolaceae) is a medicinal herb popularly used       
in Brazil for treatment of inﬂammatory and cardiovascular diseases. Despite some published data on its              
efﬁcacy, there are still few toxicological data describing the safety of this plant. The aim of this study                 
was to evaluate the (anti)estrogenic and (anti)androgenic activity of the hydroethanolic extract obtained            
from Tropaeolum majus  L. (HETM), as well as its possible effects on uterine contractility.          
Materials and methods:   Three experimental protocols were performed, (a) uterotrophic assay, (b) Her-         
shberger assay and (c) an     ex vivo  test to investigate the effects of maternal administration of HETM on          
uterine contractility at the end of pregnancy. In all protocols three doses of the HETM were administered                
to Wistar rats: 3, 30 and 300mg/kg.       ats Results: In vivo   tests for detection of (anti)androgenic and (anti)estrogenic activities did not show any sig-            
niﬁcant alterations. Similarly, no alterations were observed on uterine contractility induced by oxytocin            
and arachidonic acid.  
Conclusions:  HETM was unable to produce (anti)estrogenic or (anti)androgenic activities in the short-           
term  in vivo  screening assays performed. In addition, there was no evidence that HETM can affect uterine             
statiocontractility following ge  
. Introduction
Medicinal herbs are widely used for treatment of several dis-         
ases, as well as for research and development of new drugs. There           
reover20,000speciesbeingused in traditionalmedicineand these          
re potential sources for discovery of new therapeutic compounds
Gupta et al., 2008). Historically, in folk medicine, different ethnic
roups have used alternative therapies for treatment of diseases        
r as alimentary supplement. The widespread use of medicinal
lants is partly due to the low toxicity attributed to these natural
roducts (Ling et al., 2008). However, medicinal plants may  cause
 series of toxic effects, including metabolic disorders, alterations
n immune and endocrine system, hepatic toxicity and behavioral
ffects (Buttar and Jones, 2003; Jurgens, 2003; Gadano et al., 2006).
ue to this evidence, the FDA (Food and Drug Administration)         
escribes that when a plant is used to heal, treat or prevent some
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© 2012 Elsevier Ireland Ltd.  
human disease, this will be classiﬁed as a drug, and the suppliers           
must provide scientiﬁc evidence that the product is effective and
safe for human use (Wu et al., 2008).
Tropaeolum majus  L. (Tropaeolaceae) is a native plant of the       
Andes in South America and it is widely distributed around the          
world. In Brazil, it is popularly knownas “chaguinha”, “capuchinha”         
and “nastúrcio” (  Ferreira et al., 2004; Ferro, 2006     ). It has been used    
by the population in form of tea made from its leaves for treatment            
of several conditions, including inﬂammatoryprocesses, highblood       
pressure, edema and genitourinary tract infections (      Corrêa et al.,  
2001; Lorenzi and Matos, 2002    ).
Phytochemical studies detected the presence of fatty acids,       
benzyl isothiocyanate and ﬂavonoids in seeds and leaves of         Tropae-
olum majus  (De Medeiros et al., 2000; Mietkiewska et al., 2004;        
Zanetti et al., 2004   ). Glucosinolates were isolated from leaves of      
this plant, aswell as tetracyclic triterpenes (       Lykkesfeldt andMoller,  
1993; De Medeiros et al., 2000; Grifﬁths et al., 2001; Kleinwachter
Open access under the Elsevier OA license.et al., 2008  ). Several studies in experimental pharmacology have      
been performed with Tropaeolum majus L or compounds isolated
from it. Binet (1964) demonstrated that benzyl isothiocyanate pos-
sesses antimicrobial activity in genitourinary infections. Pintão
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t al. (1995) showed that benzyl glucosinolate isolated from Tropae-
lum majus have in vitro anticancer activity in several human
umor cell lineages. Likewise, Picciarelli et al. (1984) and Picciarelli
nd Alpi (1987) demonstrated that the triterpene curcubitacin
as antineoplastic activity. De Medeiros et al. (2000) described
ntithrombotic effect of some extracts of Tropaeolum majus L.
eaves. More recently, studies from Gasparotto et al. (2009, 2011a,b)
emonstrated diuretic and antihypertensive activity of the ethano-
ic extract of Tropaeolum majus (HETM), puriﬁed fraction and
 ﬂavonoid, isoquercitrin, from the leaves of Tropaeolum majus
. Nevertheless, despite many studies on the pharmacological
roperties of Tropaeolum majus L., several aspects of its safety
ave not yet been thoroughly studied (Wielanek and Urbanek,
006). Recently, another species of the same family, Tropaeolum
uberosum,  was reported as being able to reduce testicular func-
ion in rats following treatment with extracts prepared from the
oots (Cardenas-Valencia et al., 2008). In addition, it has been
eported that some ﬂavonoids, which are major components of
he hydroethanolic extract of Tropaeolum majus,  are potential
ndocrine active compounds (Le Bail et al., 1998).
In the last decades, there has been growing concern over the
ffects of either synthetic or natural products on the endocrine
ystems of humans and wildlife. The so-called endocrine disrup-
ors can affect development, reproduction, metabolism, immunity
nd several other hormonally dependent processes. Identiﬁcation
f potential endocrine disruptive properties of medicinal herbs
as become signiﬁcantly important, particularly because of the
ide acceptance and use of such products by sensitive popula-
ions, including children and pregnant women. The aim of the
resent study was to investigate the possible (anti)estrogenic
nd (anti)androgenic activities of the hydroethanolic extract from
eaves of Tropaeolum majus (HETM) in short-term in vivo screen-
ng tests, as well as the effects of the extract in an ex vivo assay of
terine contractility.
. Materials and methods
.1. Animals
Wistar rats were obtained from the Federal University of Parana
nd maintained in controlled conditions at 22 ± 2 ◦C and a constant
2 h light/dark cycle. Standard pellet food (Nuvital, Curitiba, PR,
razil) and tap water were available ad libitum.  All animal studies
ere carried out in accordance with the Guide for Care and Use
f Laboratory Animals adopted by the Federal University of Parana
Protocol number: 383).
.2. Plant Material
Tropaeolum majus L. leaves were collected in June 2009 from
he botanical garden of University Paranaense (UNIPAR), at 430 m
ltitude above sea level (S23◦47′55–W53◦18′48). The plant was
dentiﬁed and voucher specimens were deposited at the Herbarium
f this University under number 2230.
.3. Preparation of the hydroethanolic extracts of Tropaeolum
ajus (HETM)
Tropaeolum majus L. leaves were air-dried in an oven at 40 ◦C for
 days and the resulting dry plant was cut and pulverized. This plant
aterial was macerated for 7 days using 90% ethanol as solvent. The
olvent was then eliminated by a rotary vacuum evaporator under
educed pressure and lyophilized, representing a yield of 15.5% of
he dry material extracted.armacology 141 (2012) 418– 423 419
2.4. Drugs
17--Ethynylestradiol (95% pure; C20H24O2) and testos-
terone propionate (97% pure; C22H32O3) was obtained from
Sigma–Aldrich (Steiheim, Germany). Tamoxifen (tamoxifen citrate,
99.5% pure; C26H29NO) was  obtained from Galena Laboratory
(Curitiba, PR, Brazil) and Flutamide was  purchased from Galena
(São Paulo, SP, Brazil).
2.5. Uterotrophic assay
The uterotrophic assay have been routinely used to investigate
possible (anti)estrogenic activities of different compounds (Ashby
et al., 1997; Odum et al., 1997). Immature female rats, aged 21 ± 1
day, were randomly assigned to different experimental groups and
were treated daily for three consecutive days with HETM (3, 30 and
300 mg/kg/day). In addition, one group was  treated with distilled
water to serve as negative control, while another group received
17--ethynylestradiol (dose of 0.4 mg/kg/day by gavage) and was
used as a positive control for estrogenicity (Andrade et al., 2002).
The possible antiestrogenic activity was  tested by administration
of the same three doses of HETM (3, 30 and 300 mg/kg/day) to
female rats previously treated with 17--ethynylestradiol. The last
group received tamoxifen (dose of 10 mg/kg/day by gavage) after
17--ethynylestradiol and served as positive control for antie-
strogenicity. Twenty-four hours after the last treatment, animals
were weighed and sacriﬁced by cervical dislocation (AVMA, 2007).
Uteri were excised, trimmed free of fat, pierced, and blotted to
remove ﬂuid. The body of each uterus was cut just above its junc-
tion with the cervix and at the junction of the uterine horns with
the ovaries. Wet  uterus weight was determined and expressed as
relative weight (wet uterus weight × 100/body weight).
2.6. Hershberger assay
For the Hershberger assay, 7-week-old male rats were castrated
via the scrotum (midline incision) under anesthesia (ketamine
75 mg/kg/and xylazine 1.5 mg/kg; i.p.). Chemical treatment was
not commenced until 7 days after castration to allow for complete
recovery. Seven-week-old rats (peripubertal) were chosen as this
is the typical age used in several studies (Ashby and Lefevre, 2000;
Yamada et al., 2001).
The HETM was  given daily for 7 consecutive days by either oral
gavage (p.o.) or subcutaneous injection (s.c.). For assessment of
(anti)androgenicity, three doses of HETM (3, 30 and 300 mg/kg/day)
were administered orally to castrated animals and to testosterone-
treated males (testosterone propionate 0.25 mg/kg/day; s.c.). For
detection of androgenicity, the same doses of the HETM were
administered orally to castrated males treated with vehicle
(canola oil 1.0 mL/kg/day; s.c.). Animals treated with the vehicle
by either oral gavage (5.0 mL/kg/day) or subcutaneous injection
(1.0 mL/kg/day) were used as negative controls for androgenic-
ity, while castrated rats administered testosterone propionate
(0.25 mg/kg/day; s.c.) and vehicle (5.0 mL/kg/day p.o.) were used
as positive controls for androgenicity. Flutamide (10.0 mg/kg/day;
s.c.) given to castrated, testosterone-treated males (testosterone
propionate 0.25 mg/kg/day; s.c.), which also received the vehicle
(canola oil 5.0 mL/kg/day; p.o.), was used as a positive control
for antiandrogenicity. The dosing volume for all solutions was
5.0 mL/kg when using the oral route and 1.0 mL/kg when using
subcutaneous injections. One day after the ﬁnal administration, all
rats were weighed and sacriﬁced by cervical dislocation after deep
anesthesia (Ketamine). At necropsy, the prostate, seminal vesicle
without ﬂuid, levator ani/bulbocavernosus muscle (LABC) and glans
penis were carefully dissected free of adhering fat and weighed.
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fig. 1. Test for estrogenicity and antiestrogenicity (uterotrophic assay). Columns r
n  = 11 animals per group). **p < 0.01 and ***p < 0.001 (one-way ANOVA followed by B
xtract  of Tropaeolum majus.
ll organs were weighed and their masses expressed as relative
eights (organ weight/body weight × 100).
.7. Effect on the contractility of isolated pregnant rat uterus
Adult female rats were mated for three hours during the dark
ycle at the proportion of three females to each male. Vaginal
mears were collected daily and the day of sperm detection was
onsidered as day 0 of gestation. Pregnant rats were treated daily
rom day 8 to 21 of pregnancy with HETM (3, 30 and 300 mg/kg/day)
nd sacriﬁced at day 21 of pregnancy by deep ketamine anesthesia.
he uterus was immediately removed, placed in nutritional liquid
rebs–Henseleit, and cleaned of fat and excessive connective tis-
ue. The uterus and the myometrium were transversally sectioned
n strips of approximately 5 mm  of length at the central portion of
ach uterine horn, and each of the two obtained strips was submit-
ed to different experimental conditions. Uterine strips were placed
n a 10 mL  organ bath containing nutritional liquid Krebs-Henseleit
aintained at 32 ◦C and continuously aerated with 95% O2 and 5%
O2. Uterine strips were subjected to an optimal resting force of 1 g
nd 60 min  of stabilization. The uterine strips were initially sub-
itted to contraction with KCl (80 mM)  to verify the viability of
he tissue, and the response was considered as 100%. After 30 min,
issues were directly stimulated with arachidonic acid (0.3 mM)
r oxytocin (10 mUI/ml). In between curves, a time of 30 min  was
espected and the nutritional solution was renewed every 10 min.
ontractile isotonic responses of uterine strips were recorded using
 Kymograph and converted into percentage, compared with KCl
esponse. This procedure was repeated twice to allow a medium
alue for the contraction induced by oxytocin and arachidonic acid.
he nutritional liquid Krebs–Henseleit presents the following com-
osition (concentrations in mM):  NaCl (133), KCl (5.0), CaCl2 (2.5),
gSO4 (1.3) KH2PO4 (1.2), NaHCO3 (20) and glucose (10).
. Statistical analysis
Parametric data were analyzed by variance analysis (ANOVA)
nd differences between groups were assessed by Bonferroni’s test.
onparametric data were analyzed by Kruskals–Wallis followed by
unn’s test. Differences were considered to be statically signiﬁcant
t a probability level of 5% (p < 0.05). Preparation of graphs and sta-
istical analysis was carried out using GraphPad Prism version 5.0
or Windows (GraphPad Software, San Diego, CA, USA).ent mean ± standard error of the relative uterus weight of immature females rats
oni test). Est, estradiol (1 g/kg); Tam, tamoxifen (10 mg/kg); HETM, hydroethanolic
4. Results
4.1. Uterotrophic assay
Regarding the relative weight of the uterus there were no sig-
niﬁcant differences between the groups that received HETM and
vehicle (Fig. 1A). Administration of 17--ethinyl estradiol (positive
control) signiﬁcantly increased uterine weight, but coadministra-
tion with HETM was unable to block this uterotrophic activity
(Fig. 1A and B). On the other hand, coadministration of 17--
ethinyl estradiol and tamoxifen resulted in a signiﬁcant reduction
in uterine weight when compared to the group receiving only 17-
-ethinyl estradiol.
4.2. Hershberger assay
The data in Fig. 2A–D illustrate the results of Hershberger test.
The results demonstrate that the weight of androgen dependent
organs (seminal vesicle, prostate, LABC and glans penis) of HETM
groups did not differ from vehicle control group. HETM was also
unable to block the testosterone-induced growth of these tissues.
Anti-androgenic effects were observed only when testosterone-
treated animals were co-treated with ﬂutamide, a classic androgen
receptor antagonist.
4.3. Effect on the contractility of isolated pregnant rat uterus
The treatments performed with HETM in pregnant female rats
from gestational day 8 to 21 did not alter the response of uterine
contractility induced by oxytocin or arachidonic acid in all tested
doses, indicating lack of modulatory effects of HETM on rat uterus
(Fig. 3A and B).
5. Discussion and conclusions
In the last decade, several studies have reported some impor-
tant biological effects of Tropaeolum majus L. On the other hand,
few studies have given emphasis on possible toxic effects caused
by this species. In this regard, recently was demonstrated that
oral administration of up to 5 g/kg of infusion or hydroethanolic
extract obtained from the leaves of Tropaeolum majus did not cause
signs of acute toxicity in normotensive rats (Zanetti et al., 2003;
Gasparotto et al., 2009). Thus, the objective of the present work
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ni/bulbocavernosus muscle and glans penis relative weights (n = 8–11 animals pe
0.25  mg/kg); Flut, ﬂutamide (10 mg/kg).
as to extend the safety data of this species through investiga-
ion of possible (anti)estrogenic and (anti)androgenic activities of
he hydroethanolic extract obtained from the leaves of Tropaeolum
ajus L. (HETM), as well as its effect on uterine contractility.
Some studies performed in vivo and in vitro with Tropae-
lum tuberosus,  a member of the Tropaeolaceae family, showed
eductions in testosterone levels, as well as decreased binding of
stradiol to its receptor, when the extract obtained from the roots
f this species was tested (Johns et al., 1982; Cardenas-Valencia
t al., 2008). In addition, root extracts of Tropaeolum tuberosus
educed the testicular function of adult rats after 12, 21 and 42
ays of treatment (Cardenas-Valencia et al., 2008). On the other
ig. 3. Effect of the HETM on uterine contractility induced by arachidonic acid (0.3 mM)  (
1  of pregnancy. Columns represent mean ± standard error of the percentage relative to Kpresent mean ± standard error of the seminal vesicle, ventral prostate, levator
p). ***p < 0.001 (one-way ANOVA followed by Bonferroni test). Test, testosterone
hand, benzyl isothiocyanate, a major component Tropaeolum majus,
Tropaeolum tuberosus and cruciferous vegetables, did not change
pregnancy outcomes following rat exposure during pre- and post-
implantation periods (Adebiyi et al., 2004). Corroborating these
ﬁndings, the results obtained here did not demonstrate any changes
in tissues that are sensitive to the action of sex steroid hormones
in males and females rats.
A recent pharmacological and phytochemical study performed
with Tropaeolum majus L. revealed that ﬂavonoids, particularly iso-
quercitrin, are major components of the hydroethanolic extract
(Gasparotto et al., 2011a,b). Previously, in vitro studies performed
with ﬂavonoids in lineages of breast cancer MCF-7 cells (hormone
A) and oxytocin (10 mUI/ml) (B). Female rats were exposed to HETM from day 8 to
Cl response (n = 5 animals per group) (Kruskals–Wallis followed by Dunn’s test).
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ependent), in the absence or presence of estradiol, revealed estro-
enic and antiestrogenic responses, depending on ﬂavonoid and
oncentration tested (Le Bail et al., 1998). Isoquercitrin, the major
avonoid in the HETM, did not produce a clear dose-dependent
urve, but reduced MCF-7 cell proliferation at the highest concen-
ration tested (50 M)  either alone or in the presence of estradiol
Le Bail et al., 1998). More recently, a research performed with the
ame MCF-7 cells and isoquercitrin conﬁrmed this antiproliferative
ffect (Yang and Liu, 2009).
In the past years, several in vitro and in vivo studies have demon-
trated the anti-inﬂammatory potential of isoquercitrin (Fernandez
t al., 2005; Rogerio et al., 2007). These studies, associated with
he popular use of Tropaeolum majus L. leaves to treatment of
cute inﬂammation, make its use in pregnant women an appeal-
ng possibility (Rehecho et al., 2011). In the same way, Gasparotto
t al. (2009) suggest that the effect of one or more active compo-
ents of Tropaeolum majus partially facilitates the release of renal
rostaglandins in male and female rats. This information led us to
nvestigate the possible effects of the HETM on the contractility
f isolated pregnant rat uterus. With demonstrated, the data indi-
ate that treatment of pregnant rats with HEMT does not affect
he ex vivo uterine contractility induced by oxitocin or arachidonic
cid.
The uterotrophic assay did not reveal any change in uterine
eight following treatment with HETM at 3, 30 and 300 mg/kg/day
ither isolated or in combination with estradiol, when compared
o appropriate controls. These results indicate lack of in vivo
strogenic or anti-estrogenic activity of the HETM. At the end
f pregnancy there is a rise in estrogen levels and a decline in
he amount of progesterone, which ultimately result in upregu-
ation of oxitocin receptors in the uterus, increased production of
rostaglandins and increased uterine contractility (Muller et al.,
009). Taken together the results indicate that Tropaeolum majus
oes not modulate estrogen responses in vivo, as well as has no
bvious inﬂuence on uterine contractility.
In addition to absence of effects in the uterotrophic assay,
he results with castrated male rats (Hershberger assay) indi-
ate that the HETM is unable to elicit androgenic activities at
ested doses. Also, HETM cannot block the effects of testosterone
n androgen-sensitive tissues such as prostate, seminal vesicle,
lans penis and levator ani/bulbocavernosus muscle. However, it
s important to mention that in addition to substances that disturb
he normal interaction of hormones and their receptors, adverse
ffects in the reproductive tract can be elicit by compounds that
nduce alterations in synthesis, storage, release, transport or excre-
ion of endogenous hormones (US EPA, 1996). Most in vitro and
n vivo assays designed to screen endocrine disruptors, including
he uterotrophic and Hershberger assays, are mainly suitable to
etect classic receptor-mediated activities and may  fail to recog-
ize substances that change endogenous hormone bioavailability
o responsive cells (Andrade et al., 2002).
Despite the presence of ﬂavonoids, which have been reported
s potential endocrine active compounds, HETM was unable to
roduce (anti)androgenic or (anti)estrogenic activities in the short-
erm in vivo screening assays performed in the present study.
n addition, there was no evidence that HETM can affect uter-
ne contractility following gestational exposure of rats. Additional
tudies should be performed with Tropaeolum majus L. and its major
avonoid, isoquercitrin, to fully determine the absence of reproduc-
ive and developmental toxicity.cknowledgements
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